Age-related Cognitive Decline: Clinical Trials

4 trials for Age-related Cognitive Decline, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 recruiting, 1 unknown. 4 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 14Completed 2, Recruiting 1, Unknown 1
Phase 21Completed 1

Follow Age-related Cognitive Decline: new trials by email Literature Review of Age-related Cognitive Decline trials Research Report on Age-related Cognitive Decline

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Acute Effects of THC in Older Adult
Delta-9-THC Low Dose, Placebo, Delta-9-THC Medium Dose - Age-related Cognitive Decline
Phase 1RecruitingYale University602025-06-062026-10-09
Safety and Efficacy of Human Umbilical Cord Blood Plasma Infusion for Age-Related Cognitive Decline
Umbilical Cord Blood Plasma - Age-related Cognitive Decline
Phase 1UnknownAmerican Academy of Regenerative Medicine122021-03-012021-01-13
Dosage and Efficacy of Probucol-induced apoE to Negate Cognitive Deterioration
Probucol - Dementia of the Alzheimer Type, Age-related Cognitive Decline
Phase 1 / Phase 2CompletedDouglas Mental Health University Institute232016-04-012018-01-31
Effectiveness of a Brain-Computer Interface Based System for Cognitive Enhancement in the Normal Elderly
BrainPalTM - Alzheimer's Disease, Mild Cognitive Impairment
Phase 1CompletedDuke-NUS Graduate Medical School822012-04-012014-07-25

Narrower conditions

Alzheimer Disease (1)  ·  Cognitive Dysfunction (1)  ·  Dementia (1)

Broader conditions

Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Cognition Disorders (1)  ·  Mental Disorders (1)  ·  Nervous System Diseases (1)  ·  Neurocognitive Disorders (1)  ·  Neurodegenerative Diseases (1)  ·  Tauopathies (1)

Interventions

Brain-Computer Interfaces (1)  ·  Dronabinol (1)  ·  Probucol (1)

Sponsors

American Academy of Regenerative Medicine (1)  ·  Douglas Mental Health University Institute (1)  ·  Duke-NUS Graduate Medical School (1)  ·  Yale University (1)

Countries

Canada (1)  ·  Singapore (1)  ·  United States (1)

Top investigators

Ashley Schnakenberg Martin, PhD (1)  ·  Deepak C D'Souza, MD (1)  ·  John C Breitner, MD, MPH (1)  ·  Tih Shih Lee, MD, PhD (1)

Results publications

PMID 24260218

NIH funding

R21DA058138 (1)